Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$2.94 - $4.75 $56,480 - $91,252
-19,211 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$3.99 - $5.53 $3,990 - $5,530
1,000 Added 5.49%
19,211 $83,000
Q4 2020

Feb 10, 2021

BUY
$2.99 - $5.79 $5,382 - $10,422
1,800 Added 10.97%
18,211 $71,000
Q3 2020

Nov 12, 2020

SELL
$4.79 - $9.1 $7,448 - $14,150
-1,555 Reduced 8.66%
16,411 $81,000
Q2 2020

Aug 13, 2020

BUY
$3.61 - $11.84 $22,508 - $73,822
6,235 Added 53.15%
17,966 $129,000
Q4 2019

Feb 05, 2020

BUY
$5.78 - $8.11 $1,734 - $2,433
300 Added 2.62%
11,731 $69,000
Q3 2019

Oct 23, 2019

SELL
$6.55 - $9.36 $982 - $1,404
-150 Reduced 1.3%
11,431 $94,000
Q2 2019

Aug 14, 2019

BUY
$5.92 - $9.47 $68,559 - $109,672
11,581 New
11,581 $109,000

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $81.6M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.